HealthTree Foundation reported on a presentation by Mansour Gergi, M.D., assistant professor of medicine, at the 2024 American Society of Hematology annual conference in which he shared insights into research suggesting that blood clotting events during the first year after myelodysplastic syndromes (MDS) diagnosis may impact survival outcomes.